From January 1, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on February 25, 2020.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
63.92 USD | +0.05% | -0.23% | -21.08% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.08% | 79.59B | |
+43.29% | 749B | |
+39.42% | 605B | |
-6.68% | 351B | |
+18.89% | 328B | |
+7.93% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.14% | 167B | |
+6.57% | 165B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.